American Academy of Pediatrics

Subterms

    Latest story

    125 Shares165 Views

    How Florida’s Attempt to Let Teens Sleep Longer Fell Apart

    by

    After lawmakers required high schools to start no earlier than 8:30 a.m., school administrators complained that it was unworkable. Last month, Gov. Ron DeSantis signed a repeal.Florida’s brief attempt to let high school students sleep longer began two years ago when one of the state’s most powerful politicians listened to an audiobook.The book, “Why We Sleep,” argues that sufficient sleep is fundamental to nearly every aspect of human functioning. Paul Renner, then the Republican speaker of the State House, said reading it turned him into a “sleep evangelist”; he started tracking his own sleep and pressing the book on other lawmakers.To give teenagers more time to rest, he pushed for a new law that would require public high schools to start no earlier than 8:30 a.m. and middle schools no earlier than 8 a.m. In 2023, Florida became only the second state — after California, its political opposite — to adopt such a requirement, and it asked schools to comply by 2026.“School start times are one of those issues that both Republicans and Democrats can get behind,” Mr. Renner said in an interview.This year, it all fell apart.Facing growing opposition from school administrators who said the later times were unworkable and costly, the Legislature repealed the requirement last month.Florida’s experiment was over before it began, an example of a policy driven by a single powerful lawmaker that flopped once he was termed out of office. It also illustrates how, even as concerns grow about the well-being of American teenagers, a modest scheduling shift with broad support from scientific and medical experts can struggle to gain traction.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    More stories

    • 88 Shares189 Views

      in Elections

      Federal Report Denounces Gender Treatments for Adolescents

      by

      The H.H.S. review may set the stage for additional restrictions on gender-affirming care. Critics described it as an ideological statement.Federal health officials published a report on Thursday declaring that the use of hormonal and surgical treatments in young people with gender dysphoria lacked scientific evidence and expressing concern about long-term harms, a stark reversal from previous agency recommendations and the advice of top U.S. medical groups.The report instead prioritized the role of psychotherapy, a divisive intervention to treat gender dysphoria that many advocates and physicians have equated with so-called conversion therapy.Other parts of the review seemed to call into question the very notion that some people have a gender identity that does not align with their sex at birth.In January, President Trump signed an executive order titled “Protecting Children From Chemical and Surgical Mutilation” giving the Department of Health and Human Services 90 days to produce a report on the best practices for treating young people who say their gender does not align with their birth sex.But the order made it clear that the administration had already reached its own conclusion about gender transition treatments for minors, characterizing the “blatant harm done to children” as a “stain on our nation’s history.”The 400-page report took a more sober tone but reached a similar conclusion. In a remarkable departure from the standard for medical evidence reviews, the authors were not identified pending a post-publication review process that would begin in “the coming days.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 163 Shares169 Views

      in Elections

      Hilary Cass Says U.S. Doctors Are ‘Out of Date’ on Youth Gender Medicine

      by

      Dr. Hilary Cass published a landmark report that led to restrictions on youth gender care in Britain. U.S. health groups said it did not change their support of the care.After 30 years as one of England’s top pediatricians, Dr. Hilary Cass was hoping to begin her retirement by learning to play the saxophone.Instead, she took on a project that would throw her into an international fire: reviewing England’s treatment guidelines for the rapidly rising number of children with gender distress, known as dysphoria.At the time, in 2020, England’s sole youth gender clinic was in disarray. The waiting list had swelled, leaving many young patients waiting years for an appointment. Staff members who said they felt pressure to approve children for puberty-blocking drugs had filed whistle-blower complaints that had spilled into public view. And a former patient had sued the clinic, claiming that she had transitioned as a teenager “after a series of superficial conversations with social workers.”The National Health Service asked Dr. Cass, who had never treated children with gender dysphoria but had served as the president of the Royal College of Pediatrics and Child Health, to independently evaluate how the agency should proceed.Over the next four years, Dr. Cass commissioned systematic reviews of scientific studies on youth gender treatments and international guidelines of care. She also met with young patients and their families, transgender adults, people who had detransitioned, advocacy groups and clinicians.Her final report, published last month, concluded that the evidence supporting the use of puberty-blocking drugs and other hormonal medications in adolescents was “remarkably weak.” On her recommendation, the N.H.S. will no longer prescribe puberty blockers outside of clinical trials. Dr. Cass also recommended that testosterone and estrogen, which allow young people to develop the physical characteristics of the opposite sex, be prescribed with “extreme caution.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More